
Examining the legal frameworks for new analogues.
Toxicology plays a substantial role in helping you meet your global regulatory requirements and contributes to the growing body of scientific evidence that supports Tobacco Harm Reduction.
Whatever stage of product development or commercialization your NGP is, our experienced toxicologists will provide the insight and guidance needed to ensure the best study design and analysis so you can achieve regulatory compliance and commercial success. The close integration between our chemistry and toxicology teams, plus our expertise in NGP testing, helps deliver a differentiated service with a streamlined study design that can save costs and reduce project timelines.
Used to assist with product development, evaluate third-party products for acquisition, or identify products as regulatory submission candidates.
An assessment of risk using predictive tools including Derek Nexus, Leadscope, Toxtree, and The Organization for Economic Cooperation and Development (OECD) Toolbox.
An expert scientific review providing a critical evaluation of all available toxicological data.
A systematic literature review may be conducted as a stand-alone project, or in support of a regulatory submission.
Profiles may be tailored specifically to the chosen regulatory pathway and summarize the existing hazard data, published scientific studies, and expert body reviews.
An individual health risk assessment of ingredients used in the medium of nicotine delivery, device, packaging materials, and aerosol emissions when compared to other tobacco products.
A comprehensive regulatory report evaluating the potential health risks associated with both individual constituents and the whole-product format based on quantitative chemistry, toxicology, and exposure assessments.
Aerosol collection, sample generation for use in in vitro assays, and chemistry characterization for inhaled NGP such as e-cigarettes and heated tobacco products.
Extraction and chemistry characterization of liquid extracted from the modern oral nicotine pouches.
Identifying testing laboratories and designing study methodologies in accordance with client requirements.
Interpreting in vitro toxicology results for various validated and novel assays, including 3D models, and producing summary reports.
Novel In Vitro Method Development and Validation.
Learn more about how we can help bring your nicotine delivery product to market through our high-quality analytical testing services.
At Broughton, our consultants have deep industry knowledge across all the elements required for a PMTA. We guide you through and generate the required data, to ensure that FDA finds your applications strong and compelling.
Learn more about our activities and gain insight from our scientific and regulatory experts
4 minute read
Examining the legal frameworks for new analogues.
5 minute read
On January 16, 2025, the FDA granted marketing authorisation for Swedish Match’s Zyn nicotine pouches, marking a significant regulatory milestone for ....